US2006140917A1PendingUtilityA1
Compositions and methods for selective dissolution of nascent intravascular blood clots
Est. expiryMay 21, 2018(expired)· nominal 20-yr term from priority
A61P 7/02A61K 38/49A61K 35/18A61K 9/0019
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots, which are capable of selective dissolution of pathological nascent clots formed intravascularly, with minimal risk of unwanted dissolution of pre-existing hemostatic clots, are provided wherein fibrinolytic or anticoagulant drugs are biocompatibly coupled to red blood cell carriers.
Claims
exact text as granted — not AI-modified1 . A composition comprising a therapeutic agent biocompatibly coupled to a carrier similar in size to a red blood cell.
2 . The composition of claim 1 wherein the carrier is a red blood cell.
3 . The composition of claim 1 wherein the therapeutic agent is an anti-thrombotic agent.
4 . (canceled)
5 . A thromboprophylactic agent comprising the composition of claim 3 and a pharmaceutically acceptable vehicle.
6 . A method for preventing formation of nascent intravascular blood clots in a subject comprising administering to the subject the thromboprophylactic agent of claim 5.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.